Who founded Komo Biosciences?

Komo Biosciences was founded by Jennifer Manning.

Who are Komo Biosciences's investors?

Komo Biosciences's investors include Genesis BioCapital, Eshelman Ventures, LLC, Modi Ventures, GENERAL INCEPTION, LDV Partners.

Komo Biosciences

5 known investors

Find your way into Komo Biosciences

Paths you didn't know you had: your email and LinkedIn already hold routes to the Komo Biosciences team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

KOMO Biosciences develops genome engineering technology based on hyperactive large serine integrases to transform cell-based manufacturing of biologics and advanced therapies. The company was founded around record-breaking integrase technology for improving gene editing vectors.

Biotech Deep Tech

Founders & leadership

Jennifer Manning Founder & CEOJennifer Manning founded KOMO Biosciences, a genome engineering company developing serine integrase-mediated platforms for large-payload genome insertion, and has over 30 years of experience in biotechnology commercialization, business development, and executive leadership across life sciences and biopharmaceutical sectors. She currently serves as a Strategic Advisor and Board Member at KOMO and is Founder and Managing Partner of Starlight Advisory Group, an executive advisory firm serving biotechnology and life sciences companies.

Thomas PageActing CTO

Matt FarabaughActing CFO

Jesse B. Owens Acting CSAJesse B. Owens is a genome engineering researcher who has focused on improving targeted gene delivery since publishing work on transposase-based genomic targeting in 2012. He founded Komo Biosciences to develop integrase-based technologies for cell-based manufacturing of biologics and advanced therapies, drawing on his expertise in protein engineering and directed evolution methods including phage-assisted continuous evolution.

Board

Ray Tabibiazar Chairman of the BoardGeneral Partner at Genesis BioCapital

Investors · 5

Genesis BioCapital✓ confirmed by Komo BiosciencesChattanooga

How we know: the company's own site · funding news · Not right? Tell us

Eshelman Ventures, LLClisted by Eshelman Ventures, LLCWilmingtonvia Fred Eshelman · inferred

Modi Ventureslisted by Modi VenturesHouston

How we know: Modi Ventures's portfolio page · funding news · Not right? Tell us

GENERAL INCEPTIONreportedPalo Alto

How we know: funding news · Not right? Tell us

LDV PartnersreportedPalo Alto

How we know: funding news · Not right? Tell us

Founder mafia

2 people who came through Komo Biosciences went on to found or lead other companies.

FRANK GRAZZINI IIVP Finance, Co-founderFounded Prevent Biometrics Ray TabibiazarChairman of the BoardFounded Saliogen Therapeutics

Related companies · 3

Precision BioSciencesPrecision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).

IQVIAIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.

Curi BioCuri Bio provides a preclinical drug development platform combining 3D human tissue models of disease (cardiac and skeletal muscle), biosystems for functional analysis, and AI/ML-based insights to assess drug safety, efficacy, and potency. It serves pharmaceutical and biotech R&D teams working on drug discovery.

Companies working in the same space as Komo Biosciences.

Frequently asked questions

What does Komo Biosciences do?: KOMO Biosciences develops genome engineering technology based on hyperactive large serine integrases to transform cell-based manufacturing of biologics and advanced therapies. The company was founded around record-breaking integrase technology for improving gene editing vectors.
Who founded Komo Biosciences?: Komo Biosciences was founded by Jennifer Manning.
Who are Komo Biosciences's investors?: Komo Biosciences's investors include Genesis BioCapital, Eshelman Ventures, LLC, Modi Ventures, GENERAL INCEPTION, LDV Partners.